2658-6533Research Results in Biomedicine2658-653310.18413/2658-6533-2022-8-3-0-52808Pharmacology<strong>Studies to elucidate the effect and antiapoptotic mechanism of 2-ethyl-3-hydroxy-6-methylpyridine-n-acetyltaurinate in a rat model of retinal ischemia&ndash;reperfusion</strong><strong>Studies to elucidate the effect and antiapoptotic mechanism of 2-ethyl-3-hydroxy-6-methylpyridine-n-acetyltaurinate in a rat model of retinal ischemia&ndash;reperfusion</strong>EfimenkoSvetlana V.EfimenkoSvetlana V.spotapova96@mail.ruChernyaevaSofia S.ChernyaevaSofia S.sonyachernyaeva@yandex.ruPeresypkinaAnna A.PeresypkinaAnna A.peresypkina_a@bsu.edu.ruPobedaAnna S.PobedaAnna S.pobeda@bsu.edu.ruKorokinMikhail V.KorokinMikhail V.mkorokin@mail.ruBeskhmelnitsynaEvgeniya A.BeskhmelnitsynaEvgeniya A.evgeny_b89@mail.ruPokrovskiiMikhail V.PokrovskiiMikhail V.mpokrovsky@yandex.ruĆoracAleksandar M.ĆoracAleksandar M.aleksandar.corac@med.pr.ac.rs20228300

Background:&nbsp;The study of possible ways of effective correction of retinal ischemia-reperfusion injury, which accompanies a number of eye diseases, is relevant today. The aim of the study:&nbsp;To study the retinoprotective effect and antiapoptotic mechanism of 2-Ethyl-3-hydroxy-6-methyl-pyridine-N-acetyltaurinate (EHMP-NAT) in a rat model of retinal ischemia&ndash;reperfusion (I/R). Materials and methods:&nbsp;A pathology model with an increase in intraocular pressure (IOP) to 110 mmHg was used. The retinoprotective effect of EHMP-NAT at a dose of 4.4 mg/kg/day, in comparison with emoxipine and taurine in equimolar doses, was estimated by the changes in the retinal microcirculation, electroretinograms (the b/a coefficient), and retinal caspase-3, NF-&kappa;B p65, p53 gene expressions in Wistar rats. Results:&nbsp;The use of EHMP-NAT led to an increase in the retinal microcirculation level to 756.5 (median) perfusion units in comparison with emoxipine (p = 0.045) and taurine (p = 0.00029). The b/a coefficient increased in comparison with the group with emoxipine (p = 0.0099) and with the group with taurine (p = 0.015). In the group with EHMP-NAT, the caspase-3 gene expression decreased reliably in comparison with emoxipine (p = 0.0002) and with taurine (p = 0.0028); the NF-&kappa;B p65 gene expression decreased in comparison with emoxipine (p = 0.0009) and with taurine (p = 0.0022); the p 53 gene expression decreased in comparison with emoxipine (p = 0.0022) and with taurine (p = 0.0009).&nbsp; Conclusion:&nbsp;Based on the data obtained, in correction of retinal I/R by EHMP-NAT, improvements in the retinal microcirculation, functional state, and caspase-3, NF-&kappa;B p65, p53 gene expressions were more pronounced than in monotherapy with emoxipine or taurine.

Background:&nbsp;The study of possible ways of effective correction of retinal ischemia-reperfusion injury, which accompanies a number of eye diseases, is relevant today. The aim of the study:&nbsp;To study the retinoprotective effect and antiapoptotic mechanism of 2-Ethyl-3-hydroxy-6-methyl-pyridine-N-acetyltaurinate (EHMP-NAT) in a rat model of retinal ischemia&ndash;reperfusion (I/R). Materials and methods:&nbsp;A pathology model with an increase in intraocular pressure (IOP) to 110 mmHg was used. The retinoprotective effect of EHMP-NAT at a dose of 4.4 mg/kg/day, in comparison with emoxipine and taurine in equimolar doses, was estimated by the changes in the retinal microcirculation, electroretinograms (the b/a coefficient), and retinal caspase-3, NF-&kappa;B p65, p53 gene expressions in Wistar rats. Results:&nbsp;The use of EHMP-NAT led to an increase in the retinal microcirculation level to 756.5 (median) perfusion units in comparison with emoxipine (p = 0.045) and taurine (p = 0.00029). The b/a coefficient increased in comparison with the group with emoxipine (p = 0.0099) and with the group with taurine (p = 0.015). In the group with EHMP-NAT, the caspase-3 gene expression decreased reliably in comparison with emoxipine (p = 0.0002) and with taurine (p = 0.0028); the NF-&kappa;B p65 gene expression decreased in comparison with emoxipine (p = 0.0009) and with taurine (p = 0.0022); the p 53 gene expression decreased in comparison with emoxipine (p = 0.0022) and with taurine (p = 0.0009).&nbsp; Conclusion:&nbsp;Based on the data obtained, in correction of retinal I/R by EHMP-NAT, improvements in the retinal microcirculation, functional state, and caspase-3, NF-&kappa;B p65, p53 gene expressions were more pronounced than in monotherapy with emoxipine or taurine.

retinal ischemia–reperfusionrats2-ethyl-3-hydroxy-6-methyl-pyridine-n-acetyltaurinateapoptosisretinal ischemia–reperfusionrats2-ethyl-3-hydroxy-6-methyl-pyridine-n-acetyltaurinateapoptosisСписок литературыHardy P, Beauchamp M, Sennlaub F, et al. Inflammatory lipid mediators in ischemic retinopathy. Pharmacological Reports. 2005;57(Suppl.):169-190.Usui-Ouchi A, Ouchi Y, Ebihara N. The peroxisome proliferator-activated receptor pan-agonist bezafibrate suppresses microvascular inflammatory responses of retinal endothelial cells and vascular endothelial growth factor production in retinal pigmented epithelial cells. International Immunopharmacology. 2017;52:70-76. DOI: https://doi.org/10.1016/j.intimp.2017.08.027Xu YP, Han F, Tan J. Edaravone protects the retina against ischemia/reperfusion induced oxidative injury through the PI3K/Akt/Nrf2 pathway. Molecular Medicine Reports. 2017;16:9210-9216. DOI: https://doi.org/10.3892/mmr.2017.7739Nor Arfuzir NN, Agarwal R, Iezhitsa I, et al. Effect of Magnesium Acetyltaurate and Taurine on Endothelin1-Induced Retinal Nitrosative Stress in Rats. Curr Eye Res. 2018;43:1032-1040. DOI: https://doi.org/10.1080/02713683.2018.1467933.Peresypkina A, Pazhinsky A, Danilenko L, et al. Retinoprotective Effect of 2-Ethyl-3-hydroxy-6-methylpyridine Nicotinate. Biology (Basel). 2020;9(3):45. DOI: https://doi.org/10.3390/biology9030045. PMID: 32121045Arikan S, Ersan I, Karaca T, et al. Quercetin protects the retina by reducing apoptosis due to ischemia-reperfusion injury in a rat model. Arquivos Brasileiros de Oftalmologia. 2015;78:100-104. DOI: https://doi.org/10.5935/0004-2749.20150026Qin X, Li N, Zhang M, et al. Tetrahedral framework nucleic acids prevent retina ischemia-reperfusion injury from oxidative stress via activating the Akt/Nrf2 pathway. Nanoscale. 2019;11:20667-20675. DOI: https://doi.org/10.1039/c9nr07171gLambuk L, Iezhitsa I, Agarwal, et al. Magnesium acetyltaurate prevents retinal damage and visual impairment in rats through suppression of NMDA-induced upregulation of NF-&kappa;B, p53 and AP-1 (c-Jun/c-Fos). Neural Regeneration Research. 2021;16: 2330-2344. DOI: https://doi.org/10.4103/1673-5374.310691Li N, Gao S, Wang J, et al. Antiapoptotic effect of interleukin-17 in a mouse model of oxygen-induced retinopathy. Experimental Eye Research. 2019;187:107743. DOI: https://doi.org/10.1016/j.exer.2019.107743Ryan KM, Phillips AC, Vousden KH. Regulation and function of the p53 tumor suppressor protein. Current Opinion in Cell Biology. 2001;13:332-337. DOI: https://doi.org/10.1016/s0955-0674(00)00216-7Haupt S, Berger M, Goldberg Z, et al. Apoptosis &ndash; the p53 network. Journal of Cell Science. 2003;116:4077&ndash;4085. DOI: https://doi.org/10.1242/jcs.00739Chipuk JE, Fisher JC, Dillon CP, et al. Mechanism of apoptosis induction by inhibition of the antiapoptotic BCL-2 proteins. Proceedings of the National Academy of Sciences of the United States of America. 2008;105:20327-20332. DOI: https://doi.org/10.1073/pnas.0808036105Sot B, Freund SM, Fersht AR. Comparative biophysical characterization of p53 with the pro-apoptotic BAK and the antiapoptotic BCL-xL. Journal of Biological Chemistry. 2007;282:29193-29200. DOI: https://doi.org/10.1074/jbc.M705544200Chen YG, Zhang C, Chiang SK, et al. Increased nuclear factor-&kappa;B p65 immunoreactivity following retinal ischemia and reperfusion injury in mice. Journal of Neuroscience Research. 2003;72:125-131. DOI: https://doi.org/10.1002/jnr.10548Qin ZH, Chen RW, Wang Y, et al. Nuclear factor &kappa;B nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum. Journal of Neuroscience. 1999;19:4023-4033. DOI: https://doi.org/10.1523/JNEUROSCI.19-10-04023.1999Voronina TA. Mexidol: The spectrum of pharmacological effects. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2012;112:86-90. Russian.Chesnokova NB, Beznos OV, Pavlenko TA, et al. Effects of hydroxypyridine derivatives mexidol and emoxypin on the reparative processes in rabbit eye on the models of corneal epithelial defect and conjunctival ischemia. Bulletin of Experimental Biology and Medicine. 2015;158:346-348. DOI: https://doi.org/10.1007/s10517-015-2758-3Manin AN, Voronin AP, Drozd KV, et al. Pharmaceutical salts of emoxypine with dicarboxylic acids. Acta crystallographica. Section C, Structural chemistry. 2018;74(7):797-806. DOI: https://doi.org/10.1107/S2053229618007386Keys SA, Zimmerman WF. Antioxidant activity of retinol, glutathione, and taurine in bovine photoreceptor cell membranes. Experimental Eye Research. 1999:68:693-702. DOI: https://doi.org/10.1006/exer.1999.0657Jafri AJA, Arfuzir NNN, Lambuk L, et al. Protective effect of magnesium acetyltaurate against NMDA-induced retinal damage involves restoration of minerals and trace elements homeostasis. Journal of Trace Elements in Medicine and Biology. 2017;39:147-154. DOI: https://doi.org/10.1016/j.jtemb.2016.09.005Peresypkina AA, Pokrovskii MV, Dolzhikov AA, et al. Correction of experimental ischemic neuropathy of the optic nerve by imidazoline receptor agonist type I and II. Eksperimental&#39;naya i Klinicheskaya Farmakologiya. 2018;81:12-17. DOI: https://doi.org/10.30906/0869‐2092‐2018‐81‐4‐12‐17Chien J-Y, Lin S-F, Chou Y-Y, et al. Protective Effects of Oroxylin A on Retinal Ganglion Cells in Experimental Model of Anterior Ischemic Optic Neuropathy. Antioxidants. 2021;10:902. DOI: https://doi.org/10.3390/antiox10060902Peresypkina AA, Gubareva VO, Levkova EA, et al. Pharmacological correction of retinal ischemia/reperfusion by minoxidil. Srpski Arhiv Za Celokupno Lekarstvo. 2018;146:530-533. DOI: https://doi.org/10.2298/sarh170814006pArfuzir NN, Lambuk L, Jafri AJ, et al. Protective effect of magnesium acetyltaurate against endothelin‐induced retinal and optic nerve injury. Neuroscience. 2016;325:153-164. DOI: https://doi.org/10.1016/j.neuroscience.2016.03.041McInnis J, Wang C, Anastasio N, et al. The role of superoxide and nuclear factor-kappa B signaling in N-methyl-D-aspartate-induced necrosis and apoptosis. Journal of Pharmacology and Experimental Therapeutics. 2002;301:478-487. DOI: https://doi.org/10.1124/jpet.301.2.478Kawamoto EM, Lima LS, Munhoz CD, et al. Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-&kappa;B in the rat hippocampus. Journal of Neuroscience Research. 2012;90:213-228. DOI: https://doi.org/10.1002/jnr.22745Kitaoka Y, Kumai T, Kitaoka Y, et al. Nuclear factor-kappa B p65 in NMDA-induced retinal neurotoxicity. Molecular Brain Research. 2004;131:8-16. DOI: https://doi.org/10.1016/j.molbrainres.2004.07.021Fan W, Cooper NG. Glutamate-induced NF-&kappa;B activation in the retina. Investigative Ophthalmology and Visual Science. 2009;50:917-925. DOI: https://doi.org/10.1167/iovs.08-2555Liebermann DA, Hoffman B, Vesely D. p53 induced growth arrest versus apoptosis and its modulation by survival cytokines. Cell Cycle. 2007;6:166-170. DOI: https://doi.org/10.4161/cc.6.2.3789Singh L, Pushker N, Saini N, et al. Expression of pro-apoptotic Bax and anti-apoptotic Bcl-2 proteins in human retinoblastoma. Clinical and Experimental Ophthalmology. 2015;43:259-267. DOI: https://doi.org/10.1111/ceo.12397Lambuk L, Jafri AJ, Arfuzir NN, et al. Neuroprotective effect of magnesium acetyltaurate against NMDA-induced excitotoxicity in rat retina. Neurotoxicity Research. 2017;31:31-45. DOI: https://doi.org/10.1007/s12640-016-9658-9Maes ME, Schlamp CL, Nickells RW. BAX to basics: how the BCL2 gene family controls the death of retinal ganglion cells. Progress in Retinal and Eye Research. 2017;57:1-25. DOI: https://doi.org/10.1016/j.preteyeres.2017.01.002Riva CE, Cranstoun SD, Grunwald JE, et al. Choroidal blood flow in the foveal region of the human ocular fundus. Investigative Ophthalmology and Visual Science. 1994;35:4273-4281.Chamot SR, Movaffaghy AM, Petrig BL, et al. Blood flow in the human iris measured by laser Doppler flowmetry. Microvascular Research. 1999;57:153-161. DOI: https://doi.org/10.1006/mvre.1998.2136Riva CE, Geiser M, Petrig BL, et al. Ocular blood flow assessment using continuous laser Doppler flowmetry. Acta Ophthalmologica. 2010;88:622-629. DOI: https://doi.org/10.1111/j.1755-3768.2009.01621.xSchmidl D, Boltz A, Kaya S, et al. Comparison of choroidal and optic nerve head blood flow regulation during changes in ocular perfusion pressure. Investigative Ophthalmology and Visual Science. 2012;53:4337-4346. DOI: https://doi.org/10.1167/iovs.11-9055Mdzomba JB, Jordi N, Rodriguez L, et al. Nogo-A inactivation improves visual plasticity and recovery after retinal injury. Cell Death and Disease. 2018;9:1-14. DOI: https://doi.org/10.1038/s41419-018-0780-xFischer AJ, Zelinka C, Milani‐Nejad N. Reactive retinal microglia, neuronal survival, and the formation of retinal folds and detachments. GLIA. 2015;63:313-327. DOI: https://doi.org/10.1002/glia.22752Novikov VE, Levchenkova OS. Promising directions of search for antihypoxants and targets of their action. Experimental and clinical pharmacology. 2013;76:37-47. Russian.Lambert IH, Kristensen DM, Holm JB, et al. Physiological role of taurine&ndash;from organism to organelle. Acta Physiologica. 2015;213:191-212. DOI: https://doi.org/10.1111/apha.12365Jafri AJA, Agarwal R, Iezhitsa I, et al. Protective effect of magnesium acetyltaurate and taurine against NMDAinduced retinal damage involves reduced nitrosative stress. Molecular Vision. 2018;24:495-508.